No Data
CHI LONGEVITY: INTERIM REPORT 2024
CICC Securities: The chemical industry continued to fluctuate in the first half of the year, with strong tire exports and double growth in revenue and performance.
In the first half of 2024, the chemical industry achieved revenue of 1237.63 billion yuan, a year-on-year increase of +4.2%; net income attributable to the company was 75.25 billion yuan, a year-on-year increase of +0.8%.
chi longevity (01863.HK) mid-term revenue increased by approximately 18.9% to approximately 0.532 billion yuan
As of June 30, 2024, the company's revenue increased by approximately 18.9% to approximately RMB 5.322 million; the gross margin decreased from 18.3% to 17.4%; the net profit attributable to shareholders of the company increased by approximately 3.1% to approximately RMB 2.02 million; and the basic earnings per share were approximately RMB 2.36 cents.
"Performance" Chi Longevity Group (01863.HK) half-year net profit of 20.153 million RMB, up 3.1%, no dividend.
Chi Longevity Group (01863.HK) announced its interim performance for the six months ended June this year, with revenue of 0.532 billion RMB, representing an annual increase of 18.9%. Net profit was 20.153 million RMB, up 3.1% year-on-year; earnings per share were 2.36 cents, with no dividend. (vc/k)~
CHI LONGEVITY: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
Sealand Securities: The cyclical upturn of PX and pure benzene is expected.
The pure benzene industry has limited new production capacity, and the supply-demand imbalance is expected to continue. Stimulated by demand, it is expected that the global pure benzene industry operating rate will rebound strongly from 2024 to 2026.
No Data
No Data